Consumer advocacy group Public Citizen on Tuesday filed a petition with the U.S. Food and Drug Administration seeking to require makers of Botox and...
The US Food and Drug Administration (FDA) on Monday authorized updated COVID-19 vaccines from Pfizer/BioNTech and Moderna that target a recently circulating Omicron variant...
The US Food and Drug Administration approved Mirati Therapeutics Inc’s (MRTX.O) lung cancer drug adagrasib, the company said on Monday, sending its shares up...
WASHINGTON: Moderna's COVID-19 vaccine may have a higher risk of heart inflammation in young men than the Pfizer/BioNTech shot, according to data presented on...
WASHINGTON: The United States on Wednesday authorized Pfizer Inc's (PFE.N) antiviral COVID-19 pill for people ages 12 and older at risk of severe illness,...
The US Food and Drug Administration on Thursday authorized a booster dose of COVID-19 vaccines from Pfizer and Moderna for people with compromised immune...
An approval is highly anticipated after the drugmakers said in March that the vaccine was found to be safe, effective and produced robust antibody responses in 12- to 15-year-olds in a clinical trial
The U.S. drugs regulator said on Friday genetic variants of COVID-19, including the one found in the UK, could lead to false negative results from some molecular COVID-19 tests.
Healthcare workers and elderly people in long-term care facilities are expected to be the main recipients of a first round of 2.9 million doses this month.
'While COVID-19 diagnostic tests have been authorized for at-home collection, this is the first that can be fully self-administered and provide results at home'
The FDA, explaining its decision, cited early evidence suggesting blood plasma can decrease mortality and improve the health of patients when administered in the first three days of their hospitalization.
US health regulators approved expanding the heart benefit claims Amarin can make in promoting its drug Vascepa to include reducing the risk of heart attacks